The Diagnostic Value of the First Clinical Impression of Patients Presenting to the Emergency Department (PREKEYDIA)

October 28, 2022 updated by: Kepler University Hospital

The Diagnostic Value of the First Clinical Impression of Patients Presenting to the Emergency Department

Finding a diagnosis for acutely ill patients places high demands on emergency medical personnel. While anamnesis and clinical examination provide initial indications and allow a tentative diagnosis, both laboratory chemistry and imaging tests are used to confirm (or exclude) the tentative diagnosis. The more precise and targeted the additional laboratory chemical or radiological diagnosis, the more quickly and economically the causal treatment of the emergency patient can be initiated.

One examination modality, which in addition to the medical history and clinical examination, could quickly provide information about the condition of the patient, their clinical picture and severity of illness, is the first clinical impression of the patient (so-called "first impression" or "end-of-bed view"). This describes the first sensory impression that the medical staff gathers from a patient. This includes visual (e.g., facial expression, gait, breathing), auditory (e.g., voice pitch, shortness of breath when speaking), and olfactory (e.g., smell of exhaled air, body odor) impressions. Clinical practice shows that a great deal of important additional information can be gathered through this first clinical impression, which, together with the history and clinical examination of the emergency patient, provides valuable clues to the underlying condition.

To date, however, only scattered data and study results exist in the medical literature on the value of the first clinical impression in the care of emergency patients. In the present prospective observational study, the study attempts to evaluate the predictive value of the first clinical impression in identifying a leading symptom and other important clinical parameters.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

1506

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Upper Austria
      • Linz, Upper Austria, Austria, 4021
        • Kepler University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults presenting to the emergency department.

Description

Inclusion Criteria:

  • Patients presenting to the emergency department between 2019-09-01 and 2020-02-28.

Exclusion Criteria:

  • None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Shortness of breath
Machine Learning Prediction
Extremity pathologies
Machine Learning Prediction
Abdominal pain
Machine Learning Prediction
Urological pathologies
Machine Learning Prediction
Chest pain
Machine Learning Prediction
Back pain
Machine Learning Prediction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
AUROC for Classification of Shortness of Breath
Time Frame: 2019-09-01 to 2020-02-28
AUROC for Classification of Shortness of Breath
2019-09-01 to 2020-02-28
AUROC for Classification of Extremity Pathologies
Time Frame: 2019-09-01 to 2020-02-28
AUROC for Classification of Extremity Pathologies
2019-09-01 to 2020-02-28
AUROC for Classification of Abdominal Pain
Time Frame: 2019-09-01 to 2020-02-28
AUROC for Classification of Abdominal Pain
2019-09-01 to 2020-02-28
AUROC for Classification of Urological Pathologies
Time Frame: 2019-09-01 to 2020-02-28
AUROC for Classification of Urological Pathologies
2019-09-01 to 2020-02-28
AUROC for Classification of Chest Pain
Time Frame: 2019-09-01 to 2020-02-28
AUROC for Classification of Chest Pain
2019-09-01 to 2020-02-28
AUROC for Classification of Back Pain
Time Frame: 2019-09-01 to 2020-02-28
AUROC for Classification of Back Pain
2019-09-01 to 2020-02-28

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
AUROC for Classification of Hospital Admission
Time Frame: 2019-09-01 to 2020-02-28
AUROC for Classification of Hospital Admission
2019-09-01 to 2020-02-28
Confusion Matrix
Time Frame: 2019-09-01 to 2020-02-28
Confusion Matrix Results: true positives, true negatives, false positive, false negatives and values calculated from these results.
2019-09-01 to 2020-02-28
Descriptive Statistics
Time Frame: 2019-09-01 to 2020-02-28
Descriptive Statistics (e. g. age in years)
2019-09-01 to 2020-02-28

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Actual)

February 28, 2020

Study Completion (Actual)

February 1, 2021

Study Registration Dates

First Submitted

October 25, 2022

First Submitted That Met QC Criteria

October 25, 2022

First Posted (Actual)

October 27, 2022

Study Record Updates

Last Update Posted (Actual)

October 31, 2022

Last Update Submitted That Met QC Criteria

October 28, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PREKEYDIA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergencies

Clinical Trials on Machine Learning Prediction

3
Subscribe